Digital chemistry & Pharma IT

Immunotherapy Drugs Market Dynamics (Growth Drivers, Restraints, Opportunities and Trends) Insights by Geography and Competitive Landscape – Pharma NewsWire

The global immunotherapy drugs market valued $106.1 billion revenue in 2017 and is projected to register a CAGR of 13.6% during the period 20182023. Surge in the prevalence of chronic diseases, and thriving demand and development of monoclonal antibodies…

[ Read More ]

Wet Age-Related Macular Degeneration Market Share Analysis of the Top Industry Players, Growth Opportunities and Country Level Segments

Official Post from Pramod Kumar: The market is predominantly driven by the increase in prevalence of AMD, lack of availability of specific treatment, and surge in geriatric population, according to P&S Intelligence.Lucentis, Eylea, and Avastin are the key drugs available globally for the management of wet AMD. Among these, Eylea is

[ Read More ]